Laboratoire Gifrer - Dacudoses & Novoptine - Ownership and Business Overview

Life ScienceCompany

Laboratoire Gifrer - Dacudoses & Novoptine Ownership

Who owns Laboratoire Gifrer - Dacudoses & Novoptine?

Laboratoire Gifrer - Dacudoses & Novoptine is owned by 21 Invest. It was acquired on July 4, 2019.

Is Laboratoire Gifrer - Dacudoses & Novoptine PE-backed?

Yes. Laboratoire Gifrer - Dacudoses & Novoptine is owned by private equity investor 21 Invest.

Laboratoire Gifrer - Dacudoses & Novoptine Business Overview

Where is Laboratoire Gifrer - Dacudoses & Novoptine headquartered?

Laboratoire Gifrer - Dacudoses & Novoptine is headquartered in Décines-Charpieu, France.

What sector is Laboratoire Gifrer - Dacudoses & Novoptine in?

Laboratoire Gifrer - Dacudoses & Novoptine is a life science company.

Life Science M&A Summary in 2019

Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2019. The largest life science acquisition in 2019 was Celgene - which was acquired by Bristol-Myers Squibb for $74.0B.

Join Mergr to view all 245 acquisitions of life science companies in 2019, including 40 acquisitions by private equity firms, and 205 by strategics.

Acquired by 21 Invest (Investor) on 2019-07-04

Laboratoire Gifrer - Dacudoses & Novoptine

Laboratoire Gifrer - Dacudoses & Novoptine

Décines-Charpieu, 69150
France,

Dacudoses is a reimbursed brand of the French ophthalmic antiseptic segment, prescribed by ophthalmologists and general practitioners. Dacudoses is commonly used as an eyewash in case of light conjunctivitis and/or infections, benefitting from a very strong brand recognition in France. Novoptine is an over-the-counter antiseptic collyrium used to treat eye infections and conjunctivitis.

Company Summary

SECTOR

Investor History
2019-07-04
Divestiture

21 Invest PE

Laboratoire Gifrer

Subscribe to unlock this and 201,649
investor and company profiles

Sign-up today to get full access

Unlimited Searches
Unlimited Profile Views
Build and Export Lists of

PE Backed Companies
Direct Investors & Acquirers
Advisors
Deals
& More

1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

Stay informed on events in your industry
M&A research that takes seconds (not all afternoon)
Better understand your customers and prospects
Discover active buyers (or sellers)

Search

4.5K Private Equity Firms
193K M&A Transactions
197K Companies Involved in M&A
(Buyer, Seller, or Target)
3.6K M&A Advisors
(Investment Banks and Law Firms)
75K M&A Contacts
(PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Laboratoire Gifrer - Dacudoses & Novoptine

Life Science Companies , France Companies

Related Lists for Life Science Companies

Largest Life Science Companies , Acquisitive Life Science Companies , Recently Acquired Life Science Companies , Recently Sold Life Science Companies , Private Life Science Companies , Public Life Science Companies , Acquired Life Science Companies , PE Backed Life Science Companies

Related Lists for France Companies

Largest France Companies , Acquisitive France Companies , Recently Acquired France Companies , Recently Sold France Companies , Private France Companies , Public France Companies , Acquired France Companies , PE Backed France Companies